SCHEMBL5144162

SCHEMBL5144162

CC(C)N(C(=O)C(C#N)=Cc1ccc(C(N)=O)cc1)c1ccc2nc(S)sc2c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.39
MEN1 O00255 5/20 0.36
MAPT P10636 5/20 0.36
KMT2A Q03164 5/20 0.36
ALDH1A1 P00352 4/20 0.36
POLB P06746 2/20 0.36
TDP1 Q9NUW8 2/20 0.34
DYRK1A Q13627 1/20 0.34
SNCA P37840 1/20 0.34
MAPK1 P28482 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
NEK2 P51955 2/20 0.32
ILK Q13418 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1379573 0.92 APP (0.39) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1379571 0.92 APP (0.39) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1379586 0.90 APP (0.41) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1379587 0.90 APP (0.41) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1376039 0.90 MAPT (0.47) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1376041 0.90 MAPT (0.47) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1375570 0.89 APP (0.40) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1376393 0.89 APP (0.42) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1379601 0.89 APP (0.40) APPMEN1MAPTKMT2AALDH1A1
SCHEMBL1376394 0.89 APP (0.42) APPMEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285562-B2 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-10-23 US disclosed
EP-1648564-B1 CYANOAMIDE COMPOUNDS USEFUL AS MALONYL-COA DECARBOXYLASE INHIBITORS CHUGAI PHARMACEUTICAL CO LTD (JP) 2007-10-17 EP disclosed
EP-1648564-A1 CYANOAMIDE COMPOUNDS USEFUL AS MALONYL-COA DECARBOXYLASE INHIBITORS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-04-26 EP disclosed
WO-2005011812-A1 CYANOAMIDE COMPOUNDS USEFUL AS MALONYL-COA DECARBOXYLASE INHIBITHORS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-02-10 WO disclosed
US-20050026945-A1 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026945-A1 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors ACACA, ACACB, MCCC2 APP 2169/4885MEN1 1792/4885MAPT 2998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.